Clinical Trial Update: Study of ZIO-201 in Advanced Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

This update reports on the completion of a Phase 1/2 study of ZIO-201 in patients with advanced sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• ZIO-201

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Advanced Sarcoma | Phase 1, Phase 2 | Status: COMPLETED